Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-468
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7909.016
uM
108.46670
254.11780
0.2570 -1.0000 1.2904 0.1317
0.6828
1.3701
LY2
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
9536.019
uM
52.79420
96.35390
-0.4711 -1.0000 1.8261 0.2015
0.9497
1.5595
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
10755.15
uM
inf
inf
0.4395 0.4395 0.0000 0.2504
0.3664
0.7807
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
10473.138
uM
inf
1.19780
0.7189 0.7475 4.9965 0.0394
0.9219
1.2872
SUM159PT
TNBC
Basal B
Ribavirin
15402.211
uM
51.66870
999.82030
0.4628 -0.6950 0.2941 0.1569
0.8782
3.0887
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
12070.16
uM
1.30120
1.15090
0.2168 0.2294 4.9999 0.2666
0.9242
0.8453
HCC1806
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7830.016
uM
inf
inf
0.2581 0.2581 0.0000 0.1910
0.3538
2.0313
HCC1806
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7829.016
uM
13.43190
18.22980
-0.8442 -0.8456 3.2414 0.3225
0.9995
1.9532
MDA-MB-468
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7907.016
uM
inf
inf
0.5786 0.5786 0.0000 0.1202
0.4906
1.3145
HCC1806
TNBC
Basal A
2-deoxyglucose
12702.177
uM
556.93120
1000.00000
-0.1052 -0.4162 1.0348 0.1905
0.9832
1.5730
HCC70
TNBC
Basal A
Glycyl-H-1152
ROCK2
10873.15
uM
0.92080
0.83559
0.0558 0.0929 2.1170 0.2468
0.9894
1.1958
MDA-MB-468
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7906.016
uM
inf
inf
-0.6451 -0.6451 0.0000 0.5855
0.2634
0.8028
HCC38
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7854.016
uM
inf
7.23080
0.3700 0.5045 5.0000 0.1340
0.8222
0.9074
HCC70
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7856.016
uM
inf
11.83740
0.7410 0.6982 0.6309 0.0644
0.8127
0.9156
SK-BR-3
HER2amp
Luminal
Glycyl-H-1152
ROCK2
11851.16
uM
48.29610
344.4820
0.4174 -1.0000 0.5592 0.1148
0.9623
1.1668
SUM159PT
TNBC
Basal B
TAPI-0
TACE/Collagenase
7531.096
uM
inf
inf
0.8694 0.8694 0.0000 0.0391
0.3982
3.5504
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
7875.018
uM
123.00360
811.46460
-0.6784 -1.0000 0.5823 0.3989
0.9523
1.6565
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
10073.034
uM
869.1580
1000.00000
-0.8708 -0.5080 5.0000 0.1985
0.7391
0.5531
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
7874.018
uM
89.31090
1000.00000
-0.5749 -0.8076 0.3980 0.3580
0.6990
1.6506
HCC70
TNBC
Basal A
Glycyl-H-1152
ROCK2
12400.169
uM
0.69220
0.70339
-0.0677 -0.0418 5.0000 0.4240
0.9528
1.2449
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
9583.026
uM
321.32760
1000.00000
-0.2230 -0.3704 0.4883 0.2592
0.7368
1.2731
600MPE
HR+
Luminal
Mebendazole
13091.174
uM
14.64610
480.70650
0.3243 -1.0000 0.3147 0.2245
0.8786
0.7967
MCF 10F
NM
-
Glycyl-H-1152
ROCK2
12254.16
uM
inf
inf
0.8887 0.8887 0.0000 -0.0374
0.1921
1.4029
CAMA-1
HR+
Luminal
Ibandronate
FDPS
12070.143
uM
209.3390
252.68780
-0.7810 -0.7813 5.0000 0.2384
0.9969
0.9561
HCC1954
HER2amp
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7836.016
uM
33.93490
143.9580
-0.0804 -1.0000 0.7602 0.1638
0.9872
1.5669